Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
isoquercetin (1 trial)
masitinib (1 trial)
Coronavirus Infections (Phase 2)
Trials (1 total)
Trial APIs (2 total)